TRAIL signaling plays a main role in tumor immune-surveillance by inducing selectively apoptosis in cancer cells and sensitivity of cancer cells to TRAIL correlates with the surface level of death receptors DR4 and DR5 (Zhang et al., 1999). This evidence concerns the gene TNFRSF10A and cancer.